Cargando…
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality
Autores principales: | Fattizzo, Bruno, Giannotta, Juri Alessandro, Sciumè, Mariarita, Cattaneo, Daniele, Bucelli, Cristina, Fracchiolla, Nicola Stefano, Onida, Francesco, Baldini, Luca, Barcellini, Wilma, Iurlo, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250492/ https://www.ncbi.nlm.nih.gov/pubmed/32457356 http://dx.doi.org/10.1038/s41375-020-0877-y |
Ejemplares similares
-
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study
por: Bucelli, Cristina, et al.
Publicado: (2021) -
Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021) -
Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021) -
Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” Question
por: Barcellini, Wilma, et al.
Publicado: (2021) -
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
por: Cattaneo, Daniele, et al.
Publicado: (2021)